The abstract is read at the publisher; the summary is JClub's.
In EC-specific inducible Alk1-knockout mice, loss of ALK1 signaling induces brain arteriovenous malformations mainly in the perineural vascular plexus.
- Why it matters: Limited bAVM treatments and unclear roles for endothelial cell heterogeneity motivate identifying the specific angiogenic state and targetable pathway driving malformations.
- What they did: Single-cell RNA sequencing in Alk1iECKO mice revealed a KIT+ angiogenic endothelial population with human AVM-like transcriptional features, conserved KIT expression in sporadic and HHT2 bAVMs, and direct repression of Kit by BMP9/ALK1/SMAD4 signaling.
- The result: Pharmacological KIT inhibition reduced angiogenic reprogramming and vascular malformations in vivo without affecting normal vasculature, supporting KIT signaling as a therapeutically actionable pathway in bAVMs.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.